Vasogen Inc (NYSE:MEW - TSE:VAS) Immune Modulation Therapies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasogen Inc (NYSE:MEW - TSE:VAS) Immune Modulation Therapies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joseph C. Goldenberg who wrote (1)	2/17/2000 10:30:00 PM
From: Smacs	of 26

Joseph! You're right on the money with BOTH stocks. Vasogen is garnering alot of attention on both sides of the border these days and with good reason. Their track record so far with trials is spotless and I can only imagine how this stock will move once they get the next two drugs to clinicals. And I'm on your side re: ATY as well. It has been LONG undervalued (and still is given the recent announcements regarding e-appliances). A company with solidly increasing revenue/earnings history and a bright future as marketshare leader in a buzz-industry like e-appliances with a P/E slightly above 30? Not in today's market... I'm holding both of these and am more than pleased with results to date! -sm-

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next